Stay updated on Obeldesivir Study in High-risk COVID-19: Clinical Trial

Sign up to get notified when there's something new on the Obeldesivir Study in High-risk COVID-19: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Obeldesivir Study in High-risk COVID-19: Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0; the page remains a 403 Forbidden error page.
    Difference
    0.2%
    Check dated 2026-11-01T14:38:30.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    A site-wide banner announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” across its content.
    Difference
    1%
    Check dated 2026-10-25T14:48:04.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T15:11:12.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.0 to v3.7.1, while the study record remains behind a 403 error.
    Difference
    0.2%
    Check dated 2026-10-11T14:55:29.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study details, blocking access to the study record. The error page includes a standard header/footer, indicating the page is temporarily inaccessible.
    Difference
    17%
    Check dated 2026-09-20T19:48:22.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.5 to v3.6.6 on the study record, signaling a minor update to the page's metadata. This change typically reflects small fixes or improvements to the page rather than substantive changes to the study information.
    Difference
    0.0%
    Check dated 2026-08-30T21:58:39.000Z thumbnail image

Stay in the know with updates to Obeldesivir Study in High-risk COVID-19: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Obeldesivir Study in High-risk COVID-19: Clinical Trial page.